โ† All deals

AngioInsight, Inc.

Other Health CareAIHealthcareMedical Imaging
๐Ÿ“ Minnetonka, Minnesota, United Statesโ€ข Founded 2018
StreetZero Signal 68
Be the first to signal interest

About AngioInsight, Inc.

AngioInsight, Inc. is a medical software developer founded in 2018 and headquartered in Minnetonka, Minnesota. The company provides AI-based software for cardiologists to process angiographic images, with its flagship product AngioAI+. It has raised a total of $25.26M across three rounds, including a $25M Series A completed in October 2025. The company is privately held and operates in the biotechnology research and healthcare AI sector.

LATEST FUNDINGSeries A
$16.3M
Announced 2026-11-10
TOTAL RAISED$25.26M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for AngioInsight, Inc..

Free plan includes 3 full deal profiles every month.

Key highlights

  • Completed $25M Series A in October 2025 to launch AngioAI+.
  • Added former Johnson & Johnson medtech executive to the board during the round.
  • Total funding reached $25.26M across three rounds including grants and seed activity.
  • Focuses on AI software for processing angiographic images in cardiology.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account